You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 12, December 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular/ Cardiothoracic Surgery
 •Randomized Controlled Trial
 •Anesthesia
 •Revascularization
 •Alert me on articles by topic


Reversible Cardiac Sympathectomy by High Thoracic Epidural Anesthesia Improves Regional Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting

A Randomized Trial

Elmar Berendes, MD; Christoph Schmidt, MD; Hugo Van Aken, MD, PhD; Maike Grosse Hartlage, MD; Stefan Wirtz, MD; Holger Reinecke, MD; Markus Rothenburger, MD; Hans Heinrich Scheld, MD; Bernhard Schlüter, MD; Gerhard Brodner, MD; Michael Walter, MD

Arch Surg. 2003;138:1283-1290.

Hypothesis  To evaluate the effects of high thoracic epidural anesthesia (TEA) on global and regional myocardial function and on perioperative coronary risk in patients undergoing coronary artery bypass grafting.

Design, Setting, and Patients  Prospective and randomized clinical trial blinded for the primary outcome measure of 73 patients scheduled for coronary artery bypass grafting who had a left ventricular ejection fraction of 50% or more conducted from February 1, 2000, through August 31, 2000, at University Hospital, Münster, Germany.

Interventions  Of 73 randomized patients, 37 were control subjects (who received general anesthesia only) and 36 were in the group who received general anesthesia and high TEA.

Main Outcome Measures  The primary outcome measure was regional left ventricular function after myocardial revascularization, assessed by transesophageal echocardiography. We further determined the plasma concentrations of cardiac troponin I and atrial and brain natriuretic peptides. Secondary outcome measures were postoperative complications recorded to 14 days and mortality recorded to 720 days.

Results  High TEA was effective in all patients of this group, the somatosensory block extended from T1 through T7 vertebrae. Regional left ventricular function was significantly improved (mean [SD] global wall motion index, 0.74 [0.18] vs 0.38 [0.16]; P<.05), and cardiac troponin I concentrations were reduced by 72% (mean [SD], 5.7 [1.5] vs 1.6 [0.7] ng/mL, P<.05) in patients with high TEA. Natriuretic peptide concentrations peaked during reperfusion (atrial natriuretic peptide) and 24 hours after reperfusion (brain natriuretic peptide). High TEA reduced the mean (SD) peak concentrations of atrial natriuretic peptide by 54% (211 [63] vs 98 [33] ng/mL, P = .03) and brain natriuretic peptide by 43% (189 [39] vs 108 [21] ng/mL, P = .01). One of 36 patients who received high TEA and 3 of 37 controls died.

Conclusions  Reversible cardiac sympathectomy by high TEA improves regional left ventricular function and reduces postoperative ischemia after coronary artery bypass grafting. These effects of high TEA may improve the long-term outcome after myocardial revascularization.


From the Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin (Drs Berendes, Schmidt, Van Aken, Gross Hartlage, Wirtz, and Brodner), the Medizinische Klinik und Poliklinik C (Dr Reinecke), the Klinik und Poliklinik für Herz-, Thorax- und Gefässchirurgie (Drs Rothenburger and Scheld), the Institut für Klinische Chemie und Laboratoriumsmedizin (Dr Schlüter), Universitätsklinikum, Münster, Germany; and the Department of Biochemistry, Southwestern Medical Center at Dallas, Dallas, Tex (Dr Walter).


RELATED ARTICLE

Reversible Cardiac Sympathectomy by High Thoracic Epidural Anesthesia Improves Regional Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting—Invited Critique
Andrew E. Luckey, Cyrus J. Parsa, and Alden H. Harken
Arch Surg. 2003;138(12):1291.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epidural Anesthesia/Analgesia and Coronary Artery Bypass Surgery Utilizing Extracorporeal Circulation
Smith
Chest 2005;128:1097-1099.
FULL TEXT  

Continuous Intra- and Postoperative Thoracic Epidural Analgesia Attenuates Brain Natriuretic Peptide Release After Major Abdominal Surgery
Suttner et al.
Anesth. Analg. 2005;101:896-903.
ABSTRACT | FULL TEXT  

The Effect of High Thoracic Epidural Anesthesia on Systolic and Diastolic Left Ventricular Function in Patients with Coronary Artery Disease
Schmidt et al.
Anesth. Analg. 2005;100:1561-1569.
ABSTRACT | FULL TEXT  

Regional Anesthesia in Cardiac Surgery: A Friend or A Foe?
Djaiani et al.
SEMIN CARDIOTHORAC VASC ANESTH 2005;9:87-104.
ABSTRACT  

Sympathetic Denervation of the Heart in Reconstructive Surgery of the Coronary Vessels
Vrana and Vranova
Arch Surg 2004;139:913-913.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.